ABOUT 
SPECIALTY CARE
DIABETES RESOURCES FOR PATIENTS
JOIN OUR PATIENT COMMUNITY
What is the MCT2D Patient Advisory Board (PAB)?
At the center of our work is a group of patients and caregivers who meet six times a year to discuss and share their experiences. As a patient and/or caregiver affected by type 2 diabetes, we hope you will consider joining. As a PAB member, you will meet others and work with the MCT2D to:
- Help us understand the issues facing people with type 2 diabetes.
- Brainstorm ideas for how to better support patients and their communities.
- Give input on tools and services.
- Work together with other patients, families and caregivers.
- Help us make programs and services that work for patients in the lifelong journey of diabetes.
What Does Being a Patient Advisor Mean?
The Patient Advisory Board meets for 1 hour once every two months. The meetings are held virtually via Zoom. Members can join the meeting using their computer, tablet, smartphone, or by calling in using a home phone. Each meeting will follow a loose format where MCT2D team members will guide the conversation and get your feedback. Lively and engaging conversation from all members is encouraged and all viewpoints are heard and respected.
Patient Advisors are asked to commit to at least a year (6 meetings) of membership, although we understand that unexpected circumstances can come up that may prevent you from continuing your participation.
Patient Advisors will be required to sign a Participant Agreement and Code of Conduct Policy. This will ensure that all members feel comfortable sharing their thoughts without judgment.
For your time and participation, you will be paid $25 via check for each session you attend.
PATIENT PERSPECTIVES
Meet Shalley, MCT2D Patient Advisor
Shalley discusses why she joined the MCT2D patient advisory board and her struggles with affording an SGLT2i medication for her type 2 diabetes.
“I want to be able to contribute and make a difference.”
—Shalley, MCT2D Patient Advisory Board member and advocate for more affordable T2D medications
Upcoming PAB Meetings
Updated for 2025
- Thursday, March 20, 2025, from 4 to 5PM
- Thursday, May 15, 2025, from 4 to 5PM
- Thursday, July 17, 2025, from 4 to 5PM
- Thursday, September 18, 2025, from 4 to 5PM
- Thursday, November 20, 2025, from 4 to 5PM
Meeting Info
The Michigan Collaborative for Type 2 Diabetes (MCT2D) Patient Advisory Board meetings once every two months, on a Thursday from 4-5PM on the videoconferencing platform Zoom. To attend, download Zoom on your smart phone, tablet, or computer OR join by web browser from your computer OR call in on your phone.
Current PAB members can request the Zoom meeting link anytime. Email info@mct2d.org or text (734) 219-3220.
Tip: Most members join with their phone or web camera video ON.
PAB Downloads
Hear about low carb lifestyles from Frankie
“If I could’ve had this information as a young man, my whole life would’ve been different.”
— Frankie, who started on a lower carb lifestyle with the support of his doctor in September 2021. He's since lost 120 pounds and no longer takes insulin
Bob talks about managing his diabetes
“I’m trying to be a better diabetic, and it’s just so hard to be a better diabetic. It’s hard on me.”
— Bob, who found success adopting a lower carb lifestyle while also using a CGM
Hear about CGM from Del
“With the CGM, with this thing here, I can check [my blood sugar] 200 times a day! It should be a no brainer!”
— Del, who tried the CGM and was hooked
Are you a CGM user with type 2 diabetes?
Consider sharing your data with MCT2D!
If you use a Abbott Freestyle CGM, under your connected practices, enter the practice ID: MCT2DCGM
LEARN MOREWhy share my data?
Your data will help MCT2D show why CGMs are beneficial and should be covered by insurance for patients with type 2 diabetes.
You can turn off data sharing at any time through either LibreView or Clarity.
Subscribe to the MCT2D Newsletter
Once per month we deliver news, updates, events, and more directly to you!
ccteam@mct2d.org
Support for The Michigan Collaborative for Type 2 Diabetes (MCT2D) is provided by Blue Cross Blue Shield of Michigan as part of the BCBSM Value Partnerships program.
Although Blue Cross Blue Shield of Michigan and MCT2D work collaboratively, the opinions, beliefs and viewpoints expressed by the author do not necessarily reflect the opinions, beliefs and viewpoints of BCBSM or any of its employees.